ABIONYX PHARMA SA (ABNX.PA) Stock Analyst Earnings Estimates
EPA:ABNX - Euronext Paris - Matif - FR0012616852 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.252M 678.07% | 4.64M -11.65% | 4.551M -1.92% | 4.896M 7.58% | 6.681M 36.46% | 18.921M 183.21% | 37.643M 98.95% | |
| EBITDA YoY % growth | -3.974M 31.87% | -3.259M 17.99% | -4.33M -32.86% | -8.364M -93.16% | -7.854M 6.10% | -6.936M 11.69% | -37.667M -443.06% | |
| EBIT YoY % growth | -4.109M 30.96% | -3.412M 16.96% | -4.465M -30.86% | -8.874M -98.75% | -8.364M 5.75% | -7.344M 12.20% | -37.667M -412.89% | |
| Operating Margin | -78.24% | -73.53% | -98.11% | -181.25% | -125.19% | -38.81% | -100.06% | |
| EPS YoY % growth | N/A -25.00% | N/A 10.00% | N/A 11.11% | -0.22 -37.50% | -0.19 13.64% | -0.11 42.32% | -0.85 -657.12% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 2.207M -12.14% | % | ||
| Q2 2024 Q2Q % growth | 2.344M 10.15% | % | ||
| Q4 2023 Q2Q % growth | 2.512M -4.20% | % | ||
| Q2 2023 Q2Q % growth | 2.128M -19.09% | % | ||
| Q4 2022 Q2Q % growth | 2.622M 304.63% | % | ||
| Q2 2022 Q2Q % growth | 2.63M 9,640.74% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 4.35% | 4.35% |